Még nem keres résztvevőt itt: Egyesült ÁllamokFázis nélkül
Protocol CAUSE-05 RHINO
A legfontosabb adatok
- Ki végzi
- National Institute of Allergy and Infectious Diseases (NIAID)
- Hol
- Chicago, Cincinnati és St Louis (Egyesült Államok)Mind a 3 helyszín megnézése
- Azonosító
- Állapot
- Toborzás még nem indult
- Résztvevők
- 60 fő, tervezett
- Kezdés
- 2026. dec. 3.
- Várható befejezés
- 2027. szept. 28.
- A vizsgálat típusa
- Megfigyeléses
- A regiszteradat frissítve
- 2026. november 16.
Ki vehet részt
- Életkor
- 18 év felett
- Nem
- Csak nők
- Egészséges önkéntesek
- Részt vehetnek
A regiszter feltételei, szó szerint
Mind a 15 feltétel megnézéseKevesebb
Ki vehet részt
- Able to understand and provide informed consent
- Age 18 years or older
- Currently pregnant, with:; Gestational age ≥ 28 weeks as confirmed by participant self-report; Intent to deliver at a participating clinical site labor and delivery (L\&D) center
- Agrees to enroll infant into the study at birth
- In the case of multiple gestation, agrees to enroll only one infant who will be randomly selected
- Have a primary place of residence in one of the pre-selected recruitment census tracts as outlined in the Protocol CAUSE-05 (RHINO) Manual of Procedures (MOP) a. Participants who do not live in the pre-selected census tracts but live within the Office of Management and Budget (OMB) defined Metropolitan Statistical Area and have publicly funded health insurance will qualify for inclusion
Ki nem vehet részt
- Diagnosed at birth with any medical condition which, in the opinion of the investigator, may pose additional risks related to participation in the study, may interfere with the family's ability to comply with the protocol, or may impact the interpretation of data obtained from the study
- Known plans to move outside the pre-selected recruitment census tracts before the infant reaches 4 months of age
- Inability or unwillingness to give written informed consent or comply with study protocol
- Insufficient proficiency in English or Spanish to provide informed consent and complete study procedures
- Obstetric complications present and/or anticipated that could, in the opinion of the investigator, impact the study objectives
- Pregnancy conceived via donor oocyte (egg donation)
- Intent to transfer infant custody (e.g., via adoption or foster placement) within 4 months of birth
- Past or current medical problems that are not listed above, which, in the opinion of the investigator, may pose additional risks related to participation in the study, may interfere with the participant's ability to comply with the protocol, or may impact the interpretation of data obtained from the study; Infants who meet any of the following criteria at the Birth Visit are not eligible for further study participation:
- Delivery before 36 weeks gestation
Helyszínek itt: Egyesült Államok
- Ann & Robert H. Lurie Children's Hospital of ChicagoChicago, Egyesült ÁllamokContact: Sarah GodleyToborzás még nem indult
- Cincinnati Children's Hospital Medical CenterCincinnati, Egyesült ÁllamokContact: Molly Brausch-BradnerToborzás még nem indult
- Washington University at St. LouisSt Louis, Egyesült ÁllamokContact: Gina SimpsonToborzás még nem indult
A vizsgálatról
Mit akar kideríteni a vizsgálat
CAUSE-05/RHINO is an observational study designed to learn how babies' nasal cells grow and change during the first months of life. The study will enroll pregnant mothers in their third trimester and their infants upon delivery for a target population of 60 mother-baby pairs. Researchers will conduct up to 6 study visits and collect serial nasal samples through 4 months of age.
A vizsgálat csoportja
- Pregnant females 18 years and older and their infants upon delivery
Kérdések a vizsgálat csapatának
- Milyen gyakran kell bejárnom, és egy-egy alkalom mennyi ideig tart?
- Megtérítik az utazási költséget?
- Megtarthatom a saját orvosomat?
- Mi történik, ha ki akarok lépni?
Contact the study team: see the registry record → Contacts and Locations
Oldal nyomtatása az orvosomnakAdatok és források
- Regiszteradat
- Szerepel a ClinicalTrials.gov-on.
- Hivatalos cím
- Respiratory Health & Infant Nasal 'Omics (RHINO) (CAUSE-05)
- A regiszteradat frissítve
- 2026. november 16.